|
Volumn 35, Issue 1, 2002, Pages 79-83
|
Ranitidine and omeprazole as adjuvant therapy to pancrelipase to improve fat absorption in patients with cystic fibrosis
|
Author keywords
Antacid therapy in cystic fibrosis; Fecal fat; Pancreatic insufficiency; Pancrelipase therapy; Reproducibility of results
|
Indexed keywords
OMEPRAZOLE;
PANCREASE MT10;
PANCREASE MT16;
PANCRELIPASE;
PRILOSE;
RANITIDINE;
ADJUVANT THERAPY;
ADOLESCENT;
ADULT;
ARTICLE;
CHILD;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
CROSSOVER PROCEDURE;
CYSTIC FIBROSIS;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
ENZYME THERAPY;
FAT INTAKE;
FEMALE;
HUMAN;
LIPID ABSORPTION;
MALABSORPTION;
MALE;
PRIORITY JOURNAL;
TREATMENT OUTCOME;
ADOLESCENT;
ADULT;
CHILD;
CROSS-OVER STUDIES;
CYSTIC FIBROSIS;
DIETARY FATS;
DOUBLE-BLIND METHOD;
FEMALE;
GASTRIC ACID;
HUMANS;
INTESTINAL ABSORPTION;
MALE;
OMEPRAZOLE;
PANCRELIPASE;
PLACEBOS;
RANITIDINE;
|
EID: 0036064153
PISSN: 02772116
EISSN: None
Source Type: Journal
DOI: 10.1097/00005176-200207000-00017 Document Type: Article |
Times cited : (43)
|
References (13)
|